SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10623710
Source:
http://linkedlifedata.com/resource/pubmed/id/10623710
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0123931
,
umls-concept:C0201734
,
umls-concept:C0311400
,
umls-concept:C1709518
,
umls-concept:C1979963
,
umls-concept:C2003903
,
umls-concept:C2603343
pubmed:issue
1
pubmed:dateCreated
2000-2-17
pubmed:abstractText
To investigate the pharmacokinetics and pharmacodynamics of irinotecan and cisplatin administered once every 3 weeks in a dose-escalating study in patients with solid tumors.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Topoisomerase I Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BrouwerEE
,
pubmed-author:JacquesCC
,
pubmed-author:MathijssenR HRH
,
pubmed-author:SparreboomAA
,
pubmed-author:VernilletLL
,
pubmed-author:VerweijJJ
,
pubmed-author:de Boer-DennertM MMM
,
pubmed-author:de BruijnPP
,
pubmed-author:de JongeM JMJ
,
pubmed-author:van AlphenR JRJ
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
195-203
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10623710-Adult
,
pubmed-meshheading:10623710-Aged
,
pubmed-meshheading:10623710-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:10623710-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:10623710-Camptothecin
,
pubmed-meshheading:10623710-Cisplatin
,
pubmed-meshheading:10623710-Dose-Response Relationship, Drug
,
pubmed-meshheading:10623710-Drug Interactions
,
pubmed-meshheading:10623710-Female
,
pubmed-meshheading:10623710-Humans
,
pubmed-meshheading:10623710-Male
,
pubmed-meshheading:10623710-Maximum Tolerated Dose
,
pubmed-meshheading:10623710-Middle Aged
,
pubmed-meshheading:10623710-Statistics, Nonparametric
,
pubmed-meshheading:10623710-Topoisomerase I Inhibitors
pubmed:year
2000
pubmed:articleTitle
Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin.
pubmed:affiliation
Department of Medical Oncology, Rotterdam Cancer Institute, University Hospital Rotterdam, Rotterdam, the Netherlands.
pubmed:publicationType
Journal Article